Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-009247
Filing Date
2020-03-23
Accepted
2020-03-23 16:07:45
Documents
2
Period of Report
2020-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1566
2 EX-24 DOCUMENT attachment1.htm EX-24 3982
  Complete submission text file 0000899243-20-009247.txt   6989
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BRISTOL-MYERS SQUIBB COMPANY RT 206 & PROVINCE LINE ROAD PRINCETON NJ 08540
Business Address
Biondi Paul (Reporting) CIK: 0001744508 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 20734993